Free Trial

Venture Life Group (VLG) Share Price, News & Analysis

GBX 39.50
-0.50 (-1.25%)
(As of 05/21/2024 ET)
Today's Range
50-Day Range
52-Week Range
92,361 shs
Average Volume
163,815 shs
Market Capitalization
£49.97 million
P/E Ratio
Dividend Yield
Price Target
VLG stock logo

About Venture Life Group Stock (LON:VLG)

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti. In addition, the company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ brand. Further, it provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos, as well as Glucogel for the treatment of hypoglycaemia. Additionally, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; Baby Earol, an ear spray for babies; and Sterinase for relieving blocked noses, clearing nasal passages, and preventing the risk of allergic reactions and infections. It also provides oncology support products, such as Pomi-T, used for the management of prostate-specific antigen levels in prostate cancer; Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis; and Xonrid, a hyaluronic acid based topical gel, for the prevention and treatment of Radiation Induced Dermatitis. The company was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.

VLG Stock Price History

VLG Stock News Headlines

Big Tech's urban hero
These Are the 10 Best Hotels in Sicily
The Week in Pictures: April 19 - 26
Rising threat at the water’s edge
See More Headlines
Receive VLG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Venture Life Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Drug Manufacturers—Specialty & Generic
Year Founded


Net Income
£2.64 million
Pretax Margin


Sales & Book Value

Annual Sales
£48.57 million
Cash Flow
GBX 6.11 per share
Book Value
GBX 58 per share


Free Float
Market Cap
£49.40 million
Not Optionable
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Jeremy Anthony Philip Randall ACA (Age 60)
    Co-Founder, CEO & Executive Director
    Comp: $495.99k
  • Mr. Daniel James Wells (Age 37)
    CFO & Director
    Comp: $344.02k
  • Mr. Lodovico Gianluca Braguti (Age 64)
    Chief Manufacturing Officer & Executive Director
    Comp: $424.66k
  • Ben Colman
    Director of Corporate Development
  • Mr. Domenico Barbaro
    Head of Procurement
  • Mr. Ennio Schiro
    Head of ESG Strategy

VLG Stock Analysis - Frequently Asked Questions

How have VLG shares performed in 2024?

Venture Life Group's stock was trading at GBX 33.50 at the beginning of the year. Since then, VLG shares have increased by 17.9% and is now trading at GBX 39.50.
View the best growth stocks for 2024 here

What other stocks do shareholders of Venture Life Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Venture Life Group investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP).

How do I buy shares of Venture Life Group?

Shares of VLG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:VLG) was last updated on 5/21/2024 by Staff

From Our Partners